UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	November 10, 2022

Accession Number:	0001628280-22-029278
Submission Type:	POS AM
CIK: 0001842952 Company Name: Context Therapeutics Inc. File Number: 333-261599